These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35163991)

  • 1. Sitagliptin Is More Effective Than Gliclazide in Preventing  Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease.
    Ren J; Wang X; Yee C; Gorrell MD; McLennan SV; Twigg SM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
    Zhou ST; Cui W; Kong L; Yang X
    Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice.
    Zamani-Garmsiri F; Ghasempour G; Aliabadi M; Hashemnia SMR; Emamgholipour S; Meshkani R
    IUBMB Life; 2021 Jan; 73(1):252-263. PubMed ID: 33326684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6 J mice by modulating oxidative stress, inflammation and fibrosis.
    Lou D; Fang Q; He Y; Ma R; Wang X; Li H; Qi M
    Biomed Pharmacother; 2024 May; 174():116491. PubMed ID: 38537582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
    Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
    Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice.
    Carmona-Hidalgo B; González-Mariscal I; García-Martín A; Prados ME; Ruiz-Pino F; Appendino G; Tena-Sempere M; Muñoz E
    Phytomedicine; 2021 Jan; 81():153426. PubMed ID: 33341026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
    Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
    Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1.
    Yuting Y; Lifeng F; Qiwei H
    Biochem Biophys Res Commun; 2019 Jan; 509(1):48-55. PubMed ID: 30581002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways.
    Luo Y; Yang P; Li Z; Luo Y; Shen J; Li R; Zheng H; Liang Y; Xia N
    Drug Des Devel Ther; 2019; 13():4065-4074. PubMed ID: 31819375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.
    Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB
    Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effect of concomitant administration of sitagliptin and vitamin E on inflammatory biomarkers in rats fed with high fat diet: role of adiponectin.
    Sakr HF; Abbas AM; Khalil K; Shata AM
    J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32203939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice.
    Sun CC; Zhang CY; Duan JX; Guan XX; Yang HH; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX; Liu SK; Zhang J
    Biochem Biophys Res Commun; 2020 Mar; 523(4):1020-1026. PubMed ID: 31973813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats.
    Fawzy MH; Saeed NM; El-Sherbiny DA; El-Demerdash E
    J Pharm Pharmacol; 2021 Apr; 73(6):846-854. PubMed ID: 33822104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype.
    Farrell GC; Mridha AR; Yeh MM; Arsov T; Van Rooyen DM; Brooling J; Nguyen T; Heydet D; Delghingaro-Augusto V; Nolan CJ; Shackel NA; McLennan SV; Teoh NC; Larter CZ
    Liver Int; 2014 Aug; 34(7):1084-93. PubMed ID: 24107103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
    Ganz M; Csak T; Szabo G
    World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
    Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice.
    Zamani-Garmsiri F; Hashemnia SMR; Shabani M; Bagherieh M; Emamgholipour S; Meshkani R
    J Nutr Biochem; 2021 Jan; 87():108505. PubMed ID: 32956824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice.
    Sun H; Wang X; Chen J; Song K; Gusdon AM; Li L; Bu L; Qu S
    Lipids Health Dis; 2016 Nov; 15(1):202. PubMed ID: 27876064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.